United States v. Saint Elizabeth Medical Center, Inc.

CourtDistrict Court, E.D. Kentucky
DecidedMarch 17, 2025
Docket2:23-cv-00123
StatusUnknown

This text of United States v. Saint Elizabeth Medical Center, Inc. (United States v. Saint Elizabeth Medical Center, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Kentucky primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Saint Elizabeth Medical Center, Inc., (E.D. Ky. 2025).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF KENTUCKY NORTHERN DIVISION AT COVINGTON

CIVIL CASE NO. 23-123-DLB-CJS

UNITED STATES OF AMERICA, ex rel. VALERIE ROSE PLAINTIFF

v. MEMORANDUM ORDER

SAINT ELIZABETH MEDICAL CENTER, et al. DEFENDANTS

*** *** *** *** This matter is before the Court on the United States’ Motion to Intervene and Dismiss. (Doc. # 29). Defendants Summit Medical Group, Inc. (“Summit”) and Saint Elizabeth Medical Center, Inc. (“Saint Elizabeth”) (collectively “Defendants”) filed a joint Response (Doc. # 33), to which the United States did not reply. Relator Valerie Rose (“Relator”) also declined to respond to the United States’ Motion. Also before the Court are Defendants’ respective Motions for Judgment on the Pleadings. (Docs. # 25 and 26). Those Motions have been fully briefed and are ripe for consideration. (Docs. # 28, 30, and 31). For the following reasons, the United States’ Motion to Intervene and Dismiss (Doc. # 29) is granted. Defendants’ Motions for Judgment on the Pleadings (Docs. # 25 and 26) are denied as moot with respect to Count I and granted with respect to Count II. I. FACTUAL AND PROCEDURAL HISTORY Relator filed this qui tam action under the False Claims Act (“FCA”) and the Kentucky Medicare False Claims Statute, Ky. Rev. Stat. § 205.8463, on September 13, 2023, against Defendants. (Doc. # 1). Relator alleges that from March of 2020 to today, Defendants have been overreporting COVID-19 cases in order to defraud Medicare and Medicaid. (Doc. # 1 ¶¶ 34–35). Count I of the Complaint sought to recover under the FCA. (Id. ¶¶ 36–44). Count II of the Complaint sought to recover under Ky. Rev. Stat § 205.8463. (Id. ¶¶ 45–53).

On August 21, 2024, the United States filed a Notice of Election to Decline Intervention in this action. (Doc. # 16). This Court then Ordered that the Complaint be unsealed and served upon the Defendants. (Doc. # 17). Defendants both filed Answers to the Complaint on November 4, 2024 (Docs. # 21 and 23) and moved for Judgment on the Pleadings. (Docs. # 25 and 26). In their Memorandum in Support, Saint Elizabeth called into question the constitutionality of the FCA’s qui tam provisions. (See Doc. # 25- 1 at 4–9). Shortly thereafter the United States filed a Motion to Intervene and Dismiss on December 3, 2024. (Doc. # 29). II. THE UNITED STATES’ MOTION

A. The United States’ Right to Intervene The FCA provides that when the United States “elects not to proceed” with a qui tam action, the district court “may nevertheless permit the Government to intervene at a later date upon a showing of good cause.” 31 U.S.C. § 3730(c)(3).1 Here, the United States seeks to intervene so that it can move to dismiss the Complaint. (Doc. # 29-1 at 5). In order for the United States to move to dismiss a qui tam action under the FCA, it

1 When this Court ordered that the Complaint be unsealed it explicitly recognized that the United States retained the right to intervene at a later date for good cause. (Doc. # 17 ¶ 5) (“The United States . . . is entitled to intervene in this action, for good cause, at any time”). must first move to intervene. United States, ex rel. Polansky v. Exec. Health Res., Inc., 599 U.S. 419, 432 (2023). The reasons the United States gives for dismissal are that: (1) it has “serious concerns” about Relator’s ability to prove a viable FCA violation; and, (2) continued litigation in a fruitless FCA claim would “impose a significant resource drain” due to the

fact that the United States would have to continue to monitor the proceedings, comply with discovery obligations, and potentially defend the constitutionality of the FCA’s qui tam provisions. (Doc. # 29-1 at 8–10). Defendants stated that they do not object to the United States’ Motion to Intervene (Doc. # 33), and ostensibly neither does Relator given that she has not responded to the United States’ Motion. The United States’ proffered reasons for intervening are sufficient to establish good cause. See Polansky v. Exec. Health Res., Inc., 17 F.4th 376, 392–93 (3rd Cir. 2021) (affirming the district court’s finding of good cause where the government’s stated reasons included a desire to minimize costs of litigation, costs of document

production, and lost attorney resources defending personnel throughout the discovery process). B. The United States’ Motion to Dismiss When the United States elects to intervene in a qui tam action, it “may dismiss the action notwithstanding the objections of the person initiating the action if the person has been notified by the Government of the filing of the motion and the court has provided the person with an opportunity for a hearing on the motion.” 31 U.S.C. § 3730 (c)(2)(A). This means that the court may dismiss the action “on terms that the court considers proper.” Fed. R. Civ. P. 41(a)(2). Here, the notice and opportunity for a hearing requirement has been satisfied. § 3730(c)(2)(A). Relator has had well over three months to respond to the United States’ Motion to Dismiss, but has not objected to the dismissal. The Relator’s silence leads the Court to conclude that the Relator does not oppose dismissal. Once answers to a complaint have been filed, the standard set forth in Federal Rule of Civil Procedure 41(a)(2) becomes the appropriate standard for a district court to

use when weighing the United States’ motion for dismissal under § 3730(c)(2)(A). Polansky, 599 U.S. at 435. “[A]n action may be dismissed at the plaintiff’s request only by court order, on terms that the court considers proper.” Fed. R. Civ. P. 41(a)(2). In the FCA context, “[a] district court should think several times over before denying a motion to dismiss.” Polansky, 599 U.S. at 437–38. A district court’s “proper terms analysis” should consider the Relator’s interests. Id. at 437 (internal quotation marks omitted). Although Relator has not responded to the United States’ motion, it is possible that Relator has devoted substantial time and resources to this matter. Polansky, 599 U.S. at 437. The United States argues that continuing this qui tam action would be a waste of resources

given its “serious concerns about Relator’s ability to prove a FCA violation,” and the high costs and wasted resources associated with continuously monitoring these proceedings, complying with discovery obligations, and defending the FCA’s constitutionality. (Doc. # 29-1 at 8–10). The mere possibility that a party has devoted substantial resources to a qui tam action is no reason to deny the United States’ Motion to Dismiss, especially where the United States has maintained that justice would not be served by continuing this action, and substantial government resources would be fruitlessly wasted by allowing Relator to continue to pursue her claim. (Doc. # 29-1 at 8–10). The fact that neither Defendant objects to the proposed dismissal also favors dismissing this action. (Doc. # 33). This is especially true in a situation like this one where the Relator has not opposed dismissal. Accordingly, the United States’ Motion to Dismiss the Complaint is granted as to Count I. III. DEFENDANTS’ MOTIONS FOR JUDGMENT ON THE PLEADINGS

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Roth v. Guzman
650 F.3d 603 (Sixth Circuit, 2011)
JPMorgan Chase Bank, N.A. v. Winget
510 F.3d 577 (Sixth Circuit, 2007)
Tucker v. Middleburg-Legacy Place, LLC
539 F.3d 545 (Sixth Circuit, 2008)
Jesse Polansky v. Executive Health Resources Inc
17 F.4th 376 (Third Circuit, 2021)
Mixon v. Ohio
193 F.3d 389 (Sixth Circuit, 1999)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Saint Elizabeth Medical Center, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-saint-elizabeth-medical-center-inc-kyed-2025.